B. Riley Forecasts Abacus Life’s Q1 Earnings (NASDAQ:ABL)

Abacus Life, Inc. (NASDAQ:ABL) – Analysts at B. Riley issued their Q1 2025 EPS estimates for Abacus Life in a report issued on Monday, November 25th. B. Riley analyst M. Howlett forecasts that the company will post earnings per share of $0.25 for the quarter. B. Riley currently has a “Buy” rating and a $17.00 target price on the stock. The consensus estimate for Abacus Life’s current full-year earnings is $0.64 per share. B. Riley also issued estimates for Abacus Life’s Q2 2025 earnings at $0.26 EPS, Q3 2025 earnings at $0.27 EPS, Q4 2025 earnings at $0.27 EPS, FY2025 earnings at $1.05 EPS, Q1 2026 earnings at $0.36 EPS, Q2 2026 earnings at $0.38 EPS, Q3 2026 earnings at $0.40 EPS and FY2026 earnings at $1.56 EPS.

Abacus Life (NASDAQ:ABL) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.06. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%. The firm had revenue of $28.15 million for the quarter, compared to the consensus estimate of $26.08 million. During the same period last year, the firm earned $0.01 earnings per share.

Other equities analysts also recently issued reports about the stock. TD Cowen started coverage on shares of Abacus Life in a research note on Wednesday, August 7th. They set a “buy” rating and a $14.00 price objective on the stock. B. Riley Financial restated a “buy” rating and issued a $16.00 target price on shares of Abacus Life in a research note on Friday, August 30th. Northland Capmk upgraded shares of Abacus Life to a “strong-buy” rating in a research note on Thursday, October 24th. Piper Sandler restated an “overweight” rating and issued a $13.00 target price (up from $12.00) on shares of Abacus Life in a research note on Friday, November 8th. Finally, Northland Securities assumed coverage on shares of Abacus Life in a research note on Thursday, October 24th. They issued an “outperform” rating and a $13.50 target price for the company. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $14.70.

Abacus Life Price Performance

NASDAQ ABL opened at $8.08 on Wednesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.29 and a current ratio of 1.29. The firm’s 50 day moving average price is $9.22 and its 200-day moving average price is $9.75. Abacus Life has a 52-week low of $6.56 and a 52-week high of $13.25. The company has a market cap of $603.17 million, a PE ratio of -43.44 and a beta of 0.15.

Insider Transactions at Abacus Life

In related news, insider Matthew Ganovsky sold 156,250 shares of the firm’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $8.00, for a total transaction of $1,250,000.00. Following the completion of the transaction, the insider now owns 10,847,047 shares of the company’s stock, valued at $86,776,376. This trade represents a 1.42 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jay J. Jackson sold 2,031,250 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $8.00, for a total transaction of $16,250,000.00. Following the transaction, the chief executive officer now directly owns 10,562,000 shares of the company’s stock, valued at approximately $84,496,000. This trade represents a 16.13 % decrease in their position. The disclosure for this sale can be found here. Insiders own 79.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Allspring Global Investments Holdings LLC purchased a new position in Abacus Life in the second quarter valued at $9,909,000. Principal Financial Group Inc. purchased a new position in Abacus Life in the second quarter valued at $8,105,000. Point72 Asset Management L.P. purchased a new position in Abacus Life in the second quarter valued at $5,190,000. Mendon Capital Advisors Corp purchased a new position in Abacus Life in the second quarter valued at $4,974,000. Finally, Clearbridge Investments LLC purchased a new position in Abacus Life in the second quarter valued at $4,342,000.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.